Fidelity Investments’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.9M | Buy |
8,321,657
+218,257
| +3% | +$895K | ﹤0.01% | 1623 |
|
|
2026
Q1 | $33.5M | Sell |
8,103,400
-395,700
| -5% | -$1.48M | ﹤0.01% | 1579 |
|
|
2025
Q4 | $34M | Buy |
+8,499,100
| New | +$30.9M | ﹤0.01% | 1584 |
|
|
2025
Q3 | – | Sell |
-1,697
| Closed | -$3.22K | – | 5598 |
|
|
2025
Q2 | $3.22K | Buy |
1,697
+326
| +24% | +$1.33K | ﹤0.01% | 4787 |
|
|
2025
Q1 | $9.72K | Buy |
1,371
+1,214
| +773% | +$16.7K | ﹤0.01% | 4507 |
|
|
2024
Q4 | $3.45K | Sell |
157
-214
| -58% | -$3.41K | ﹤0.01% | 4729 |
|
|
2024
Q3 | $7.46K | Buy |
371
+251
| +209% | +$5.24K | ﹤0.01% | 4520 |
|
|
2024
Q2 | $2.09K | Buy |
120
+36
| +43% | +$1.18K | ﹤0.01% | 4719 |
|
|
2024
Q1 | $3.52K | Buy |
84
+59
| +236% | +$1.64K | ﹤0.01% | 4599 |
|
|
2023
Q4 | $620 | Sell |
25
-28
| -53% | -$681 | ﹤0.01% | 4798 |
|
|
2023
Q3 | $1.72K | Sell |
53
-518
| -91% | -$22.6K | ﹤0.01% | 4572 |
|
|
2023
Q2 | $33.2K | Buy |
+571
| New | +$29.3K | ﹤0.01% | 3634 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5231 |
|
|
2022
Q4 | – | Sell |
-333
| Closed | -$17K | – | 5611 |
|
|
2022
Q3 | $17K | Buy |
+333
| New | +$11.5K | ﹤0.01% | 3915 |
|
|
2022
Q1 | – | Sell |
-1,768
| Closed | -$121K | – | 5545 |
|
|
2021
Q4 | $121K | Sell |
1,768
-3,326
| -65% | -$421K | ﹤0.01% | 3048 |
|
|
2021
Q3 | $808K | Sell |
5,094
-1,993
| -28% | -$328K | ﹤0.01% | 2727 |
|
|
2021
Q2 | $1.38M | Hold |
7,087
| – | – | ﹤0.01% | 2610 |
|
|
2021
Q1 | $1.83M | Hold |
7,087
| – | – | ﹤0.01% | 2488 |
|
|
2020
Q4 | $1.37M | Sell |
7,087
-310
| -4% | -$60.9K | ﹤0.01% | 2473 |
|
|
2020
Q3 | $1.5M | Sell |
7,397
-15,863
| -68% | -$3.8M | ﹤0.01% | 2356 |
|
|
2020
Q2 | $6.5M | Hold |
23,260
| – | – | ﹤0.01% | 1963 |
|
|
2020
Q1 | $6.98M | Sell |
23,260
-6,740
| -22% | -$1.91M | ﹤0.01% | 1816 |
|
|
2019
Q4 | $9.63M | Hold |
30,000
| – | – | ﹤0.01% | 1862 |
|
|
2019
Q3 | $11.4M | Hold |
30,000
| – | – | ﹤0.01% | 1780 |
|
|
2019
Q2 | $13.5M | Buy |
+30,000
| New | +$15.2M | ﹤0.01% | 1775 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | – | – | 4232 |
|
|
2018
Q3 | $0 | Sell |
1
-6,157
| -100% | -$2.61M | ﹤0.01% | 3827 |
|
|
2018
Q2 | $4.02M | Sell |
6,158
-2,425
| -28% | -$7.94M | ﹤0.01% | 2198 |
|
|
2018
Q1 | $35.4M | Sell |
8,583
-22
| -0.3% | -$64K | ﹤0.01% | 1453 |
|
|
2017
Q4 | $19.8M | Buy |
+8,605
| New | +$21.8M | ﹤0.01% | 1732 |
|
Other funds holding XFOR
BCLSI
PA
SVCM
EAM
DTC
KCM
NMC
Fidelity Investments's XFOR Position: Q2 2026 in Review
Fidelity Investments increased its X4 Pharmaceuticals (XFOR) stake by 2.7% in Q2 2026, buying an estimated $895K and bringing the position to 8,321,657 shares worth $38.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1623.
Fidelity Investments first reported a position in XFOR in Q4 2017 and has held it in 28 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.
- Fidelity Investments held 8,321,657 shares of X4 Pharmaceuticals worth $38.9M as of Q2 2026.
- Fidelity Investments bought 218,257 X4 Pharmaceuticals shares in Q2 2026, an estimated $895K.
- X4 Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1623 holding.
- Fidelity Investments first reported a position in X4 Pharmaceuticals in Q4 2017 and has held it in 28 quarters since.
- 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.